MAPT and Alzheimer disease: Whilst individuals with AD can develop motor symptoms [155], this is not considered the primary deficit, indicative that the location of tau changes within the brain (e.g., hippocampus versus substantia nigra or motor cortex) and peripheral nervous system is likely an important determinant of symptoms.